Form 8-K - Current report:
SEC Accession No. 0001558370-24-008882
Filing Date
2024-06-04
Accepted
2024-06-04 09:30:15
Documents
54
Period of Report
2024-06-04
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K glyc-20240604x8k.htm   iXBRL 8-K 42909
2 EX-99.1 glyc-20240604xex99d1.htm EX-99.1 14991
3 EX-99.2 glyc-20240604xex99d2.htm EX-99.2 49551
4 GRAPHIC glyc-20240604xex99d1g001.jpg GRAPHIC 253683
5 GRAPHIC glyc-20240604xex99d1g002.jpg GRAPHIC 207163
6 GRAPHIC glyc-20240604xex99d1g003.jpg GRAPHIC 223773
7 GRAPHIC glyc-20240604xex99d1g004.jpg GRAPHIC 167838
8 GRAPHIC glyc-20240604xex99d2g001.jpg GRAPHIC 215059
9 GRAPHIC glyc-20240604xex99d2g002.jpg GRAPHIC 200184
10 GRAPHIC glyc-20240604xex99d2g003.jpg GRAPHIC 134369
11 GRAPHIC glyc-20240604xex99d2g004.jpg GRAPHIC 118795
12 GRAPHIC glyc-20240604xex99d2g005.jpg GRAPHIC 146728
13 GRAPHIC glyc-20240604xex99d2g006.jpg GRAPHIC 172488
14 GRAPHIC glyc-20240604xex99d2g007.jpg GRAPHIC 137419
15 GRAPHIC glyc-20240604xex99d2g008.jpg GRAPHIC 140665
16 GRAPHIC glyc-20240604xex99d2g009.jpg GRAPHIC 146908
17 GRAPHIC glyc-20240604xex99d2g010.jpg GRAPHIC 146949
18 GRAPHIC glyc-20240604xex99d2g011.jpg GRAPHIC 145733
19 GRAPHIC glyc-20240604xex99d2g012.jpg GRAPHIC 125886
20 GRAPHIC glyc-20240604xex99d2g013.jpg GRAPHIC 174884
21 GRAPHIC glyc-20240604xex99d2g014.jpg GRAPHIC 144104
22 GRAPHIC glyc-20240604xex99d2g015.jpg GRAPHIC 126439
23 GRAPHIC glyc-20240604xex99d2g016.jpg GRAPHIC 187039
24 GRAPHIC glyc-20240604xex99d2g017.jpg GRAPHIC 184641
25 GRAPHIC glyc-20240604xex99d2g018.jpg GRAPHIC 138618
26 GRAPHIC glyc-20240604xex99d2g019.jpg GRAPHIC 126464
27 GRAPHIC glyc-20240604xex99d2g020.jpg GRAPHIC 111817
28 GRAPHIC glyc-20240604xex99d2g021.jpg GRAPHIC 126717
29 GRAPHIC glyc-20240604xex99d2g022.jpg GRAPHIC 168285
30 GRAPHIC glyc-20240604xex99d2g023.jpg GRAPHIC 144675
31 GRAPHIC glyc-20240604xex99d2g024.jpg GRAPHIC 122442
32 GRAPHIC glyc-20240604xex99d2g025.jpg GRAPHIC 142584
33 GRAPHIC glyc-20240604xex99d2g026.jpg GRAPHIC 170376
34 GRAPHIC glyc-20240604xex99d2g027.jpg GRAPHIC 130578
35 GRAPHIC glyc-20240604xex99d2g028.jpg GRAPHIC 197880
36 GRAPHIC glyc-20240604xex99d2g029.jpg GRAPHIC 113065
37 GRAPHIC glyc-20240604xex99d2g030.jpg GRAPHIC 187218
38 GRAPHIC glyc-20240604xex99d2g031.jpg GRAPHIC 186389
39 GRAPHIC glyc-20240604xex99d2g032.jpg GRAPHIC 133802
40 GRAPHIC glyc-20240604xex99d2g033.jpg GRAPHIC 132295
41 GRAPHIC glyc-20240604xex99d2g034.jpg GRAPHIC 112829
42 GRAPHIC glyc-20240604xex99d2g035.jpg GRAPHIC 105782
  Complete submission text file 0001558370-24-008882.txt   8585044

Data Files

Seq Description Document Type Size
43 EX-101.SCH glyc-20240604.xsd EX-101.SCH 3510
44 EX-101.LAB glyc-20240604_lab.xml EX-101.LAB 15361
45 EX-101.PRE glyc-20240604_pre.xml EX-101.PRE 10380
57 EXTRACTED XBRL INSTANCE DOCUMENT glyc-20240604x8k_htm.xml XML 4612
Mailing Address 9708 MEDICAL CENTER DRIVE ROCKVILLE MD 20850
Business Address 9708 MEDICAL CENTER DRIVE ROCKVILLE MD 20850 240-243-1201
GLYCOMIMETICS INC (Filer) CIK: 0001253689 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36177 | Film No.: 241016245
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)